Abstract
A fibroid (also known as fibroma, myoma, fibromyoma and leiomyoma) is a benign tumor of the uterus which arises from the smooth muscle cells of the myometrium. The estimated incidence between 15% and 30% is almost certainly conservative, with a peak between 35 and 50 years.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American College of Obstetricians and Gynecologists (1994) Uterine leiomyomata. ACOG Technical Bulletin 192, Washington, DC
American Fertility Society (1992) Myomas and reproductive dysfunction: guideline for practice. The American Fertility Society, Birmingham, AL
Buttram VC Jr, Reiter RC (1981) Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36:433–445
Quade BJ (1995) Pathology, cytogenetics, and molecular biology of uterine leiomyomas and other smooth muscle lesions. Curr Opin Obstet Gynecol 7:35–42
Vollenhoven BJ, Lawrence AS, Healy DL (1990) Uterine fibroids: a clinical review. Br J Obstet Gynaecol 97:285–298
Ayhan A, Tuncer R, Tuncer ZS et al (1994) Correlation between clinical and histopathologic risk factors and lymph node metastases in early endometrial cancer (a multivariate analysis of 183 cases). Int J Gynecol Cancer 4:306–309
Creasman WT, Morrow CP, Bundy BN et al (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60:2035–2041
Frei KA, Kinkel K (2001) Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 13:850–855
Mariani A, Maurice JW, Keeney GL et al (2003) Endometrial cancer: predictors of peritoneal failure. Gynecol Oncol 89:236–242
Sartori E, Gadducci A, Landoni F et al (2001) Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer 11:430–437
Trimble EL, Kosary C, Park RC (1998) Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 71:340–343
Wilson TO, Podtraz KC, Gaffey TA et al (1990) Evaluation of unfavourable histologic subtypes in endometrial adenocarcinoma. Am J Obset Gynecol 162:418–426
Zaino RJ, Kurman RJ, Diana KL, Morrow CP (1996) Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage. A Gynecologic Oncology Group Study. Cancer 77:1115–1121
Magrina JF, Goodrich MA, Lidner TK et al (1999) Modified radical hysterectomy in the treatment of early squamous cervical cancer. Gynecol Oncol 72:183–186
Markman M (2007) HPV vaccines to prevent cervical cancer. Lancet 369:1837–1839
Mathur SP, Mathur RS, Creasman WT et al (2005) Early non invasive diagnosis of cervical cancer. Cancer Biomark 1:183–191
Rose PG, Bundy BN, Watkins EB et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Eng J Med 340:1144–1153
Zand KR, Reinhold C, Abe H et al (2007) Magnetic resonance imaging of the cervix. Cancer Imaging 7:769–776
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag
About this chapter
Cite this chapter
Sartori, E., Gatti, D., Quaglia, F. (2009). Clinical Approach to Uterine Disease. In: Grazioli, L., Olivetti, L. (eds) Imaging of Urogenital Diseases. Springer, Milano. https://doi.org/10.1007/978-88-470-1344-5_19
Download citation
DOI: https://doi.org/10.1007/978-88-470-1344-5_19
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1343-8
Online ISBN: 978-88-470-1344-5
eBook Packages: MedicineMedicine (R0)